Neurobiology of Aging
Volume 31, Issue 10 , Pages 1690-1699 , October 2010

Candidate anti-Aβ fluorene compounds selected from analogs of amyloid imaging agents

  • Hyun-Seok Hong

      Affiliations

    • M.I.N.D. Institute and Department of Pathology and Laboratory Medicine, University of California Davis Medical Center, 2805 50th Street, Sacramento, CA 95817, United States
    • ,
  • Izumi Maezawa

      Affiliations

    • M.I.N.D. Institute and Department of Pathology and Laboratory Medicine, University of California Davis Medical Center, 2805 50th Street, Sacramento, CA 95817, United States
    • ,
  • Madhu Budamagunta

      Affiliations

    • Department of Biochemistry and Molecular Medicine, University of California, Davis, CA 95616, United States
    • ,
  • Sandeep Rana

      Affiliations

    • Department of Chemistry, Kansas State University, Manhattan, KS 66506, United States
    • ,
  • Aibin Shi

      Affiliations

    • Department of Chemistry, Kansas State University, Manhattan, KS 66506, United States
    • ,
  • Robert Vassar

      Affiliations

    • Department of Cell and Molecular Biology, Northwestern University, Chicago, IL 60611, United States
    • ,
  • Ruiwu Liu

      Affiliations

    • Division of Hematology and Oncology, Department of Internal Medicine, University of California Davis Medical Center, Sacramento, CA 95817, United States
    • ,
  • Kit S. Lam

      Affiliations

    • Division of Hematology and Oncology, Department of Internal Medicine, University of California Davis Medical Center, Sacramento, CA 95817, United States
    • ,
  • R. Holland Cheng

      Affiliations

    • Department of Molecular and Cellular Biology, University of California, Davis, CA 95616, United States
    • ,
  • Duy H. Hua

      Affiliations

    • Department of Chemistry, Kansas State University, Manhattan, KS 66506, United States
    • ,
  • John C. Voss

      Affiliations

    • Department of Biochemistry and Molecular Medicine, University of California, Davis, CA 95616, United States
    • ,
  • Lee-Way Jin

      Affiliations

    • M.I.N.D. Institute and Department of Pathology and Laboratory Medicine, University of California Davis Medical Center, 2805 50th Street, Sacramento, CA 95817, United States
    • Corresponding Author InformationCorresponding author at: M.I.N.D. Institute and Department of Pathology and Laboratory Medicine, University of California Davis Medical Center, 2805 50th Street, Sacramento, CA 95817, United States. Tel.: +1 916 703 0392; fax: +1 916 703 0370.

Received 3 July 2008 ,Revised 13 September 2008 ,Accepted 30 September 2008.

References 

  1. Bordwell FG, Cheng JP, Seyedrezai SE, Wilson CA. Properties of anions, radicals, and radical cations derived from 9-(dialkylamino)fluorenes. J. Am. Chem. Soc. 1988;110(24):8178–8183
  2. Cai L, Innis RB, Pike VW. Radioligand development for PET imaging of beta-amyloid (Abeta)—current status. Curr. Med. Chem. 2007;14(1):19–52
  3. Cataldo AM, Petanceska S, Terio NB, Peterhoff CM, Durham R, Mercken M, et al. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Neurobiol. Aging. 2004;25(10):1263–1272
  4. Cheng IH, Scearce-Levie K, Legleiter J, Palop JJ, Gerstein H, Bien-Ly N, et al. Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J. Biol. Chem. 2007;282(33):23818–23828
  5. Dolev I, Michaelson DM. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade. Proc. Natl. Acad. Sci. U.S.A. 2004;101(38):13909–13914
  6. Hong HS, Maezawa I, Yao N, Xu B, Diaz-Avalos R, Rana S, et al. Combining the rapid MTT formazan exocytosis assay and the MC65 protection assay led to the discovery of carbazole analogs as small molecule inhibitors of Abeta oligomer-induced cytotoxicity. Brain Res. 2007;1130(1):223–234
  7. Hubbell WL, Cafiso DS, Altenbach C. Identifying conformational changes with site-directed spin labeling. Nat. Struct. Biol. 2000;7(9):735–739
  8. Jin LW, Shie FS, Maezawa I, Vincent I, Bird T. Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities. Am. J. Pathol. 2004;164(3):975–985
  9. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300(5618):486–489
  10. Kayed R, Sokolov Y, Edmonds B, McIntire TM, Milton SC, Hall JE, et al. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 2004;279(45):46363–46366
  11. Klein WL, Stine WB, Teplow DB. Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiol. Aging. 2004;25(5):569–580
  12. Kung HF, Lee CW, Zhuang ZP, Kung MP, Hou C, Plossl K. Novel stilbenes as probes for amyloid plaques. J. Am. Chem. Soc. 2001;123(50):12740–12741
  13. Kung MP, Hou C, Zhuang ZP, Zhang B, Skovronsky D, Trojanowski JQ, et al. IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques. Brain Res. 2002;956(2):202–210
  14. Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, et al. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J. Neurosci. 2004;24(45):10191–10200
  15. LaFerla FM, Green KN, Oddo S. Intracellular amyloid-beta in Alzheimer's disease. Nat. Rev. Neurosci. 2007;8(7):499–509
  16. Lee CW, Kung MP, Hou C, Kung HF. Dimethylamino-fluorenes: ligands for detecting beta-amyloid plaques in the brain. Nucl. Med. Biol. 2003;30(6):573–580
  17. Lee VM. Amyloid binding ligands as Alzheimer's disease therapies. Neurobiol. Aging. 2002;23(6):1039–1042
  18. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature. 2006;440(7082):352–357
  19. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443(7113):787–795
  20. Maezawa I, Hong HS, Wu HC, Battina SK, Rana S, Iwamoto T, et al. A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-beta oligomeric complexes. J. Neurochem. 2006;98(1):57–67
  21. Maezawa I, Hong HS, Liu R, Wu CY, Cheng RH, Kung MP, et al. Congo red and thioflavin-T analogs detect Abeta oligomers. J. Neurochem. 2008;104(2):457–468
  22. McLaurin J, Golomb R, Jurewicz A, Antel JP, Fraser PE. Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta-induced toxicity. J. Biol. Chem. 2000;275(24):18495–18502
  23. Mishra B, Priyadarsini KI, Mohan H, Mugesh G. Horseradish peroxidase inhibition and antioxidant activity of ebselen and related organoselenium compounds. Bioorg. Med. Chem. Lett. 2006;16(20):5334–5338
  24. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 2006;26(40):10129–10140
  25. Oddo S, Caccamo A, Tran L, Lambert MP, Glabe CG, Klein WL, et al. Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J. Biol. Chem. 2006;281(3):1599–1604
  26. Pardridge WM. Blood–brain barrier delivery. Drug Discov. Today. 2007;12(1–2):54–61
  27. Takahashi RH, Almeida CG, Kearney PF, Yu F, Lin MT, Milner TA, et al. Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J. Neurosci. 2004;24(14):3592–3599
  28. Townsend M, Cleary JP, Mehta T, Hofmeister J, Lesne S, O’Hare E, et al. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers. Ann. Neurol. 2006;60(6):668–676
  29. Walsh DM, Klyubin I, Fadeeva JV, Rowan MJ, Selkoe DJ. Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem. Soc. Trans. 2002;30(4):552–557
  30. Zhuang ZP, Kung MP, Hou C, Plossl K, Skovronsky D, Gur TL, et al. IBOX(2-(4′-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain. Nucl. Med. Biol. 2001;28(8):887–894
  31. Zhuang ZP, Kung MP, Hou C, Skovronsky DM, Gur TL, Plossl K, et al. Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates. J. Med. Chem. 2001;44(12):1905–1914
  32. Zhuang ZP, Kung MP, Hou C, Ploessl K, Kung HF. Biphenyls labeled with technetium 99m for imaging beta-amyloid plaques in the brain. Nucl. Med. Biol. 2005;32(2):171–184

PII: S0197-4580(08)00355-2

doi: 10.1016/j.neurobiolaging.2008.09.019

Neurobiology of Aging
Volume 31, Issue 10 , Pages 1690-1699 , October 2010

Article Tools

* Image Usage & Resolution